Literature DB >> 33754006

Peri-tumoral brain edema associated with glioblastoma correlates with tumor recurrence.

Xingping Qin1,2, Rui Liu3, Farhana Akter4, Lingxia Qin5, Qiurong Xie6, Yanfei Li7, Haowen Qiao8, Wen Zhao8, Zhihong Jian1, Renzhong Liu1, Songlin Wu9.   

Abstract

Glioblastoma is the most common malignant tumor of the brain. Despite advances in treatment, the prognosis for the condition has remained poor. Glioblastoma is often associated with peritumoral brain edema (PTBE), which can result in increased intracranial pressure and devastating neurological sequelae if left untreated. Surgery is the main treatment for glioblastoma, however current international surgical guidelines do not specify whether glioblastoma-induced PTBE tissue should be resected. In this study, we analyzed treatment outcomes of PTBE using surgical resection. We performed a retrospective analysis of 255 cases of glioblastoma between 2014 and 2016, and found that a significant proportion of patients had a degree of PTBE. We found that surgical resection led to reduction in midline shift that had resulted from edema, however, postoperative complications and KPS scores were not significantly different in the two conditions. We also observed a delay in glioblastoma recurrence in patients undergoing PTBE tissue resection vs patients without resection of PTBE tissue. Interestingly, there was an abnormal expression of tumor associated genes in PTBE, which has not been previously been found. Taken together, this study indicates that glioblastoma-induced PTBE should be investigated further particularly as the tumor microenvironment is a known therapeutic target and therefore interactions between the microenvironment and PTBE should be explored. This study also highlights the importance of resection of PTBE tissue to not only reduce the mechanical obstruction associated with edema but also to delay recurrence of glioblastoma. © The author(s).

Entities:  

Keywords:  Glioblastoma; Peritumoral brain edema; Recurrence; Tumor resection.

Year:  2021        PMID: 33754006      PMCID: PMC7974512          DOI: 10.7150/jca.53198

Source DB:  PubMed          Journal:  J Cancer        ISSN: 1837-9664            Impact factor:   4.207


  29 in total

Review 1.  Molecular heterogeneity of glioblastoma and its clinical relevance.

Authors:  Katalin Eder; Bernadette Kalman
Journal:  Pathol Oncol Res       Date:  2014-08-27       Impact factor: 3.201

2.  Nuclear PKM2 regulates the Warburg effect.

Authors:  Weiwei Yang; Zhimin Lu
Journal:  Cell Cycle       Date:  2013-08-26       Impact factor: 4.534

3.  The relative value of postoperative versus preoperative Karnofsky Performance Scale scores as a predictor of survival after surgical resection of glioblastoma multiforme.

Authors:  Lola B Chambless; Heather M Kistka; Scott L Parker; Laila Hassam-Malani; Matthew J McGirt; Reid C Thompson
Journal:  J Neurooncol       Date:  2014-10-26       Impact factor: 4.130

4.  Lactic acid induces lactate transport and glycolysis/OXPHOS interconversion in glioblastoma.

Authors:  Ke Duan; Zhong-Jian Liu; Su-Qiong Hu; Hong-Yu Huo; Zhi-Ru Xu; Jian-Fei Ruan; Yang Sun; Li-Ping Dai; Chang-Bao Yan; Wei Xiong; Qing-Hua Cui; Hai-Jing Yu; Min Yu; Yang Qin
Journal:  Biochem Biophys Res Commun       Date:  2018-06-21       Impact factor: 3.575

Review 5.  The role of glioma stem cells in chemotherapy resistance and glioblastoma multiforme recurrence.

Authors:  Brenda Auffinger; Drew Spencer; Peter Pytel; Atique U Ahmed; Maciej S Lesniak
Journal:  Expert Rev Neurother       Date:  2015-05-31       Impact factor: 4.618

6.  The prognostic significance of midline shift at presentation on survival in patients with glioblastoma multiforme.

Authors:  E S Gamburg; W F Regine; R A Patchell; J M Strottmann; M Mohiuddin; A B Young
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-12-01       Impact factor: 7.038

7.  Neuronal Activity Promotes Glioma Growth through Neuroligin-3 Secretion.

Authors:  Humsa S Venkatesh; Tessa B Johung; Viola Caretti; Alyssa Noll; Yujie Tang; Surya Nagaraja; Erin M Gibson; Christopher W Mount; Jai Polepalli; Siddhartha S Mitra; Pamelyn J Woo; Robert C Malenka; Hannes Vogel; Markus Bredel; Parag Mallick; Michelle Monje
Journal:  Cell       Date:  2015-04-23       Impact factor: 41.582

8.  Peritumoral edema on MRI at initial diagnosis: an independent prognostic factor for glioblastoma?

Authors:  K Schoenegger; S Oberndorfer; B Wuschitz; W Struhal; J Hainfellner; D Prayer; H Heinzl; H Lahrmann; C Marosi; W Grisold
Journal:  Eur J Neurol       Date:  2009-04-14       Impact factor: 6.089

9.  ERK 1/2 Activation Mediates the Neuroprotective Effect of BpV(pic) in Focal Cerebral Ischemia-Reperfusion Injury.

Authors:  Rui Liu; Jun-Chun Tang; Meng-Xian Pan; Yang Zhuang; Ya Zhang; Hua-Bao Liao; Dan Zhao; Yang Lei; Rui-Xue Lei; Shu Wang; An-Chun Liu; Xing-Ping Qin; Juan Chen; Zhi-Feng Zhang; Qi Wan
Journal:  Neurochem Res       Date:  2018-06-07       Impact factor: 3.996

Review 10.  PTEN: Multiple Functions in Human Malignant Tumors.

Authors:  Michele Milella; Italia Falcone; Fabiana Conciatori; Ursula Cesta Incani; Anais Del Curatolo; Nicola Inzerilli; Carmen M A Nuzzo; Vanja Vaccaro; Sabrina Vari; Francesco Cognetti; Ludovica Ciuffreda
Journal:  Front Oncol       Date:  2015-02-16       Impact factor: 6.244

View more
  2 in total

Review 1.  Tertiary Lymphoid Structures in the Central Nervous System: Implications for Glioblastoma.

Authors:  Tiarne van de Walle; Alessandra Vaccaro; Mohanraj Ramachandran; Ilkka Pietilä; Magnus Essand; Anna Dimberg
Journal:  Front Immunol       Date:  2021-09-01       Impact factor: 7.561

2.  Machine Learning and Radiomic Features to Predict Overall Survival Time for Glioblastoma Patients.

Authors:  Lina Chato; Shahram Latifi
Journal:  J Pers Med       Date:  2021-12-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.